顾美芳

顾美芳 (board member) discloses dealings in 昭衍新药 to SSE / SZSE (CSRC). Over a trading history stretching from 23 June 2022 to 6 September 2022, the count stands at 2 filings.

On the market, this insider has only sold: 2 sales, €89.5M in total.

The record was last updated on 6 September 2022 with an open-market sale (€21.3M) in 昭衍新药. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SSE / SZSE (CSRC). Past trades are no guide to future returns.